Make a ppt of 20 slides on topic endometriosis in adolescent from this article and standard text books
Reading File
Reading File
Reading File
Reading File
Finding Sources
Running Command
Reading File
Reading File
Running Command
Reading File
Running Command
Running Command
Writing File
Running Command
Running Command
The presentation is ready. Here's your download link:
Endometriosis in Adolescents
Presentation · PPTX
Presentation Overview — 20 Slides
The deck uses a deep plum/rose/gold medical color palette and is structured as follows:
| # | Slide Title | Content Source |
|---|---|---|
| 1 | Title Slide | Overview |
| 2 | Presentation Outline | All 20 topics listed |
| 3 | Definition & Classification | Three types: superficial, endometrioma, DIE — Robbins Pathology |
| 4 | Epidemiology | Key statistics (60–75% in adolescents with pain) — UpToDate article |
| 5 | Pathogenesis | 5 theories: retrograde menstruation, metaplasia, lymphatic spread, stem cells, immune aberration |
| 6 | Risk Factors Unique to Adolescents | Congenital anomalies, genetic factors, family history (7× risk) |
| 7 | Diagnostic Delay | 4–9 year delays; patient vs. clinician contributing factors |
| 8 | Clinical Features & Symptoms | Cyclic/acyclic pain, bowel/bladder symptoms, comorbidities |
| 9 | Associated Diagnoses & Alarm Findings | Autoimmune, migraine; ovarian torsion red flags |
| 10 | Initial Evaluation – History | 8 key history domains including abuse screening |
| 11 | Physical Exam & Lab Tests | Exam approach; CA-125 NOT recommended |
| 12 | Imaging Modalities | US (first-line), MRI, CT — with limitations |
| 13 | Definitive Diagnosis & ASRM Staging | Stages I–IV; laparoscopy as gold standard |
| 14 | Presumptive Clinical Diagnosis | When to treat without surgery; ACOG/ESHRE guidelines |
| 15 | Differential Diagnosis | Gynecologic, GI, urologic, neurologic, musculoskeletal |
| 16 | Unique Populations | Endometrioma/DIE in teens; gender-diverse adolescents |
| 17 | QoL & Psychosocial Impact | Academic, mental health, fertility outcomes |
| 18 | Initial Medical Management | NSAIDs + hormonal therapy algorithm |
| 19 | GnRH Agonists/Antagonists & Add-back | Dosing, bone considerations, elagolix/relugolix |
| 20 | Surgical Management & Summary | Surgical indications, multidisciplinary approach, key message |
This is a shared conversation. Sign in to Orris to start your own chat.